New Delhi, India

Navin Khanna

USPTO Granted Patents = 5 


 

Average Co-Inventor Count = 2.8

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2017-2024

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Inventor Navin Khanna: Pioneering Innovations in Vaccine Development

Introduction

Navin Khanna, an accomplished inventor based in New Delhi, India, has made significant contributions to the field of biotechnology, particularly in vaccine development. With a total of five patents to his name, Khanna is recognized for his commitment to advancing public health through innovative solutions.

Latest Patents

Among his notable inventions, the latest are focused on a tetravalent dengue vaccine. The invention provides a recombinant polypeptide comprising the EDIII domain of each of the four dengue virus serotypes: DENV-1, DENV-2, DENV-3, and DENV-4. This innovative approach links these domains to the N-terminal of HBsAg, showcasing Khanna's cutting-edge work in immunology.

Career Highlights

Navin Khanna has had a distinguished career within esteemed organizations such as the International Centre for Genetic Engineering and Biotechnology and Sun Pharmaceutical Industries Limited. His roles in these companies have allowed him to lead research initiatives that align with his passion for developing life-saving vaccines.

Collaborations

Throughout his career, Khanna has collaborated with skilled professionals including Viswanathan Ramasamy and Pradip Kumar Bhatnagar. These partnerships have not only enriched his research endeavors but have also contributed to the success of his various innovations.

Conclusion

With a strong dedication to innovation and a track record of impactful patents, Navin Khanna continues to influence the biotechnology landscape. His work in developing the tetravalent dengue vaccine exemplifies the pivotal role of inventors in addressing global health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…